Analysis of factors associated with thrombocytopenia in Chinese patients receiving intravenous linezolid therapy
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: DONG, Haiyan (The First Affiliated Hospital of Xi’an Jiaotong University, Department of Pharmacy, Xi'an, China)
- Co-author(s): Dong, Y. (The First Affiliated Hospital of Xi’an Jiaotong University, Xi'an, China)
The major adverse effect of linezolid is reversible myelosuppression, mostly thrombocytopenia. However, little is known about the risk factors in China.
The aim was to investigate the risk factors associated with thrombocytopenia in Chinese patients.
This study was a retrospective review for patients who were treated with The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.